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In 16 patients with pulmonary fibrosis, an artificial pneumothorax was introduced using the Veress 
cannula and the Saugman water manometer. Atmospheric air was introduced by fractionated insuffla- 
tion to a total volume of 800 ml (median). The interpleural space was found on the first attempt, and in 
all cases, fractionated insufflation of atmospheric air was conducted while the intrapleural pressure was 
controlled with the water manometer. In one case, the procedure was stopped because of a rise in the 
pleural pressure after insufflation of only 50 ml air. This was undoubtedly caused by pleural adhesions 
not visible on chest X-ray. The main concern with air insufflation is air embolism but this was not 
observed clinically in any of the present cases. The patients in the present study all suffered from 
pulmonary fibrosis judged by clinical examination, chest X-ray and pulmonary function tests. Despite a 
diffusion capacity (DCONA) with a median value of 48% expected, the procedure was well tolerated. It 
has previously been shown that artificial pneumothorax preceding thoracoscopy is well tolerated due to 
hyperventilation, with an increase in respiratory frequency and a fall in arterial CO, concentration 
(PaCO,), while pH and arterial 0, concentration (PO,) remain constant. This probably also explains the 
tolerance of the patients in this material. Insufflation of air as described here should be restricted to 
senior pulmonologists because it is an infrequent procedure. The present authors found the procedure to 
be uncomplicated and easy to perform with little discomfort to the patients. 
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Introduction 
Artificial pneumothorax in patients with severe 
phthisis was first reported by Forlanini 1894 (1). 
Forlanini used a closed method (‘die Punktions- 
metode’) of administering nitrogen, in contrast to 
Murphy and Brauer who incised the skin and muscle 
(‘die Snittmetode’) and introduced large volumes of 
gas intrapleurally (2,3). Saugman introduced the 
water manometer in 1906, making it possible to 
introduce gas into the pleural space under controlled 
circumstances (4) and thoracoscopy and cauteriza- 
tion of adhesions were introduced by Jacobeus in 
1913 (5). A summary of these historical milestones 
has been compiled by Sakula (6). The introduction of 
the Veress cannula in 1984 for introducing artificial 
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pneumothorax in pulmonary diseases has made this 
procedure easy (7). The aim of the present study 
was to evaluate the effectiveness and safety of the 
Veress cannula in introducing a pre-thoracoscopic 
artificial pneumothorax in 16 patients with presumed 
pulmonary fibrosis. 
Materials and Methods 
Sixteen patients with a median age of 50 years 
(range: 24-70 years), nine males and seven females, 
with diffuse bilateral reticulonodular changes (by 
conventional chest X-ray) were examined. 
The following procedure was performed by trained 
senior pulmonologists. After oral pre-medication 
with 10 mg diazepam and local anaesthesia of the 
skin and intercostal muscle, a skin incision was made 
in the mid-axillary region. The Veress cannula (Plate 
l), connected to the Saugman water manometer 
(Plate 2) was introduced through the skin. In all 
cases, the operator could feel when the parietal pleura 
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PLATE 1. (a) The Veress cannula in toto with 
springloaded blunt cannula, (b) the separated blunt 
inner cannula with side-hole (arrow), and (c) the 
separated sharp outer cannula. 
was perforated, and observe negative respiratory fluc- 
tuations on the manometer. Air insufflation was 
performed fractionated until the pleural pressure 
neared zero, or 800-1000 ml air had been insufflated. 
The reason for not allowing air into the pleural space 
through an open cannula is the advantage gained by 
knowing the exact amount of air insufflated under 
continual observation of the pleural pressure. The 
Veress cannula was withdrawn, and the closed artifi- 
cial pneumothorax was confirmed by either chest 
roentgenogram or fluoroscopy. Thoracoscopy was 
performed with local anaesthesia (8). 
In all patients, measurements of lung function were 
performed including forced expiratory volume in 
1 s (FEV,), forced vital capacity (FVC), residual 
volume (RV), total lung capacity (TLC) and diffusion 
capacity (DCOIVA: ml min - ’ mmHg - ’ I- ’ ). 
(d) 
PLATE 2. The water manometer is a modification of Saugman’s original model. (a) Bottle with sterile 
water open to the atmosphere (double arrow). Elevation of the bottle forces the water into the vial (c) by 
gravity. (b) Stopcock separating the insufflation instruments from the water manometer and the patient. 
(d) The water manometer. The arrow shows the connection to the Veress cannula and to the patient. When 
negative respiratory fluctuations are observed, the stopcock (b) is opened and fractionated air could be 
insufflated under continuous observation of the pleural pressure. For later equalization with the 
atmosphere, the vial (c)‘s stopcock (marked with double double arrow), can be opened after stopcock 
(b) has been closed. 
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TABLE 1. Pleural pressure before and after air insufflation in relation to volume of air 
insufflated and the pulmonary function (n= 16) 
Patient Pre- Pre- Post- Post- Volume 4% 
number inspir expir inspir expir insuffl (years) Sex FEV,% FVC% DIFF 
1 -6 -2 -2 0 1000 37 F 90 101 41 
2 -4 -2 -2 0 700 41 M 94 90 47 
3 -5 -3 -2 -1 800 55 M 94 111 49 
4 -4 -2 -2 0 900 66 F 84 112 20 
5 -7 -4 * * 800 70 F 95 107 45 
6 -4 -2 -1 0 1500 69 M 77 71 49 
7 -3 -2 -1 0 1000 59 M 45 47 65 
8 -6 -2 -4 -1 600 45 F * * * 
9 -9 -5 * * 700 44 F 83 92 28 
10 -6 -4 -1 0 1000 24 F 57 58 66 
11 -6 -2 X * 1500 44 M 50 63 67 
12 -4 -2 -1 0 750 59 F 92 88 39 
13 -6 -2 -2 0 600 41 M * * * 
14 -6 -2 -2 0 800 69 M 69 79 67 
15 -7 -2 -4 -2 800 60 M 84 92 41 
16 -4 -2 -2 5 50 39 M 85 89 50 
Median -6 -2 -2 0 800 50 84.5 89.5 48 
SD 1.55 0.97 1.00 1.61 341.0 13.81 16.82 19.95 14.45 
SE Mean 0.39 0.24 0.28 0.45 85.3 3.45 4.50 5.33 3.86 
Pre-inspir/expir, the pleural pressure measured in cmH,O before fractionated insufflation 
of atmospheric air; post-inspir/expir, the pleural pressure measured in cmH,O after 
fractionated insufflation of atmospheric air; volume insufflated, atmospheric air in ml; 
FEV,%, forced expiratory volume in 1 s in relation to the expected value in percent before 
air insufflation; FVC%, forced vital capacity in relation to the expected value in percent 
before air insufflation; DIFF, DACONA (ml min - ’ mmHg 1 - ‘, single-breath diffusion 
capacity in relation to the expected value in percent before air insufflation. 
*missing values. 
Statistical Analysis 
Only descriptive statistics are employed. The lung 
volume and the diffusion capacity are reported in 
relative values [(actual value/expected value) x loo)]. 
Results 
In all 16 cases, the Veress cannula was introduced 
into the pleural space on the first attempt and the 
artificial pneumothorax was established without com- 
plications. 
The pre-inspiratory/pre-expiratory pleural pressure 
was - 6/ - 2 cmH,O (median), and the post- 
inspiratorylpost-expiratory pressure was - 2/O cmH,O 
(median). 
The total volume of atmospheric air insufflated 
was 800 ml (median) (range: 600-1500 ml), and in 
all cases, except Case 16, the insufflation was clini- 
cally well tolerated and established a pneumothorax 
very suitable for subsequent thoracoscopy. No air 
embolism occurred. 
In one patient (Case 16), the insufflation was 
stopped because of rapid increase in the pleural 
pressure which occurred after insufflation of only 
50 ml air. 
The median RV% was 102, and the median TLC% 
was 82.50. The median DCONA was 49% of pre- 
dicted normal value. The demographic data is shown 
in Table 1. 
Discussion 
In a previous report (7), 19 patients had experienced 
induced pneumothorax with Veress cannula and 
Saugman’s water manometer with ease and without 
any complications. 
Before this era, the original Saugman cannula 
was used (9). This is more difficult to position and 
maintain in the pleural cavity, The cannula model 
by Kjer-Petersen (10) with a side-gap in the inner 
cannula was close to the idea of the Veress cannula, 
but Saugman’s and Kjer-Petersen’s cannulae were 
sharp whilst the Veress inner-cannula is blunt with a 
side opening permitting registration of the pleural 
pressure and fractionated air insufflation (Plate 1). 
In this study of 16 patients with suspected pulmo- 
nary fibrosis, the pleural cavity was found on the first 
attempt and fractionated insufflation of atmospheric 
air under control of the water manometer was 
achieved (4,7). In one patient, the procedure was 
stopped because of a rise in pleural pressure after 
insufflation of only 50 ml air. This was undoubtedly 
caused by pleural adhesions not visible on chest 
X-ray. The main concern with air insufflation is air 
embolism but this was not observed clinically in any 
of the patients. The pressure with which air was 
insufflated never exceeded 10 cmH,O, and inflation 
was stopped if the patient experienced discomfort or 
resistance to insufflation was experienced. In this way, 
air embolism, tearing of adhesions or cardiac distur- 
bances were avoided. Different gases, usually nitro- 
gen, have been introduced into the pleural cavity 
(IA) because nitrogen is absorbed more slowly from 
the cavity than, for example, oxygen or atmospheric 
air (11). This was significant in the collapse treatment 
of the tubercular lung, but as a pre-thorascopic 
preparation, insufflation of atmospheric air seems to 
be a practical and simple solution. In some studies 
(12) CO, insufflation has been used, but this is 
without proven advantage. 
The patients in this study presumably suffered from 
pulmonary fibrosis. Despite a diffusion capacity with 
a median value of 48% expected, the procedure was 
well tolerated. It has previously been shown (13) that 
artificial pneumothorax preceding thoracoscopy is 
well tolerated on account of hyperventilation, with an 
increase in respiratory frequency, a fall in PaCO, and 
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pH and PO, remaining constant. This is probably 
also the reason for the good tolerance in this study. 
Air insufflation as described here should be per- 
formed by a senior physician with practical experi- 
ence, as well as a good knowledge of respiratory 
physiology. Under these circumstances, the procedure 
is easy, safe and uncomplicated with little discomfort 
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